Document Detail


Factors associated with radiographic progression in patients with rheumatoid arthritis who were treated with methotrexate.
MedLine Citation:
PMID:  21078715     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
OBJECTIVE: To identify factors associated with radiographic progression at 52 weeks in patients with rheumatoid arthritis (RA) after 12 weeks of methotrexate (MTX) therapy.
METHODS: The study population consisted of patients from the MTX arm of the Trial of Etanercept and Methotrexate with Radiographic Patient Outcomes (TEMPO). Logistic regression analysis was used to identify clinical and laboratory assessments performed at Week 12 of MTX therapy that might be associated with Week 52 radiographic outcome (modified total Sharp score). Classification and regression tree (CART) modeling of the Week 12 assessments was used to determine the subgroups of patients with the best and worst radiographic outcomes.
RESULTS: A total of 169 patients were analyzed: 116 patients in the best radiographic outcome group and 53 patients in the worst radiographic outcome group. Logistic regression analysis showed that Week 12 C-reactive protein (CRP) level, erythrocyte sedimentation rate, tender joint count, swollen joint count (SJC), and Health Assessment Questionnaire scores were significantly associated with radiographic progression at Week 52 (p < 0.05 for each assessment). CART modeling showed that patients with Week 12 CRP > 0.67 mg/dl and SJC > 1 and patients with Week 12 CRP ≤ 0.67 mg/dl and SJC > 10 were likely to show the worst radiographic progression at Week 52. The CART model had a sensitivity of 85%, specificity of 60%, and overall classification accuracy of 68%.
CONCLUSION: In patients with RA, measures of CRP and SJC after 12 weeks of MTX therapy emerged as the factors most associated with radiographic progression at Week 52.
Authors:
Michael E Weinblatt; Edward C Keystone; Marc D Cohen; Bruce Freundlich; Juan Li; Yun Chon; Scott W Baumgartner
Related Documents :
8895145 - Autonomic nervous system function in rheumatoid arthritis. a controlled study.
16999205 - Microvascular abnormalities in patients with rheumatoid arthritis.
7032425 - Immunofluorescence microscopic studies of recurrent aphthous stomatitis.
25087695 - Myeloid microvesicles in csf are associated with myelin damage and neuronal loss in mil...
22981405 - The role of protein-bound uremic toxins on peripheral artery disease and vascular acces...
8707125 - Role of paraoesophageal collaterals and perforating veins on outcome of endoscopic scle...
Publication Detail:
Type:  Journal Article     Date:  2010-11-15
Journal Detail:
Title:  The Journal of rheumatology     Volume:  38     ISSN:  0315-162X     ISO Abbreviation:  J. Rheumatol.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-02-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7501984     Medline TA:  J Rheumatol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  242-6     Citation Subset:  IM    
Affiliation:
Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115, USA. mweinblatt@partners.org.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of cells expressing mesenchymal stem cell markers in healthy and osteoarthritic synov...
Next Document:  Progressive loss of lymphatic vessels in skin of patients with systemic sclerosis.